Their flagship product, the GILUPI CellCollector®, is the world's first in vivo CTC collection product with a CE certification. It uses a gold-coated stainless steel wire with bound antibodies to specifically isolate circulating tumor cells from the blood for further analysis. The CellCollector® provides doctors with additional information about a patient's disease state and helps them tailor personalized cancer treatments. The company has obtained a license to commercialize the product in China and Hong Kong, where it will be used in clinical settings.